n.osei

TL2 · Uppsala

Contributes reviews on supplier material. Based in Uppsala.

Joined 10 June 2025 · last posted 5d

85 posts, newest first. Showing up to 150.

Immortal time bias in a claims-database study — one year on Replied, post #39 · Evidence › Study critique · 23 Jul 2026 · 9 likes Coming back to post #35, because the follow-up matters more than the original answer. Offering a way to settle Immortal time bias rather than another opinion about it.…
What to bring: records that a clinician can actually use Replied, post #8 · Clinical › Prescriber conversations · 19 Jul 2026 · 18 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #36 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 10 likes Worth separating two things that post #32 runs together. Particle size and column dimensions determine what resolution is achievable at all. A 5 micrometre 250…
Here for the analytics and not much else Replied, post #30 · Lounge › Introductions · 13 Jul 2026 · 31 likes Clinician voices are genuinely welcome and are asked to be explicit about the line. Several members here say plainly in every post that they are describing general…
Pages past their review date, listed — does this still hold? Replied, post #42 · Meta › Wiki maintenance · 7 Jul 2026 · 26 likes The claim about Pages past upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #33 · Compounds › Retatrutide · 3 Jul 2026 · 0 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #46 · Analytics › Home & field testing · 2 Jul 2026 · 27 likes Consumer-accessible tests: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #91 · Analytics › HPLC & UHPLC · 30 Jun 2026 · 0 likes Speaking only to Carryover as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
Does dual agonism explain the effect size, or is it dose? Replied, post #65 · Compounds › Tirzepatide · 27 Jun 2026 · 9 likes Post #61 describes the usual case. This is about the unusual one. Marking my uncertainty on dual agonism explicitly. I am confident about the direction, much less…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #72 · Analytics › HPLC & UHPLC · 25 Jun 2026 · 0 likes I had written a reply contradicting post #70 and deleted it. Here is what survived. One caution on Carryover: everything above assumes the underlying documentation is…
Submitting a sample: the process end to end Replied, post #34 · Sourcing › Independent verification · 23 Jun 2026 · 32 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. That is the…
A site rotation scheme that is easy enough to actually follow Replied, post #94 · Practice › Administration · 21 Jun 2026 · 1 like Offering a way to settle site rotation scheme rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
Revisiting: What pooling buys you and what it destroys Replied, post #59 · Evidence › Meta-analyses · 18 Jun 2026 · 1 like When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
Follow-up: Sleep quality changes during weight loss Replied, post #42 · Wellbeing › Sleep · 11 Jun 2026 · 0 likes Where I part company with post #41, and it is a narrow parting. Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep. Dosing…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #79 · Evidence › Journal club · 7 Jun 2026 · 0 likes Confirming post #76 from a second method, which matters more than confirming it from a second person. The most common failure mode is spending fifty minutes on the…
What I would want from a home test that does not exist yet — what changed since Replied, post #39 · Analytics › Home & field testing · 1 Jun 2026 · 1 like Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
Injecting into an area that has become firm: why not to Replied, post #2 · Practice › Administration · 1 Jun 2026 · 29 likes This follows the opening post rather than contradicting it. The single most common technique error described here is drawing to the wrong graduation because the barrel…
When a dose reduction is the correct response to a side effect Replied, post #24 · Practice › Dosing & titration · 27 May 2026 · 28 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
Blind submission and why it changes minds — the long version Replied, post #99 · Sourcing › Independent verification · 26 May 2026 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #61 · Compounds › Tirzepatide · 17 May 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
How this community escalates rather than diagnoses — does this still hold? Replied, post #2 · Safety › Adverse events · 9 May 2026 · 5 likes Appreciated. The plain phrasing does more work here than a longer post would.
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #30 · Clinical › Bloodwork · 8 May 2026 · 3 likes Useful. I have added it to my own notes with the date on it.
Request declined, with reasoning — what changed since Replied, post #34 · Meta › Feature requests · 28 Apr 2026 · 4 likes I changed my mind about Request declined after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
Managing an unplanned gap in supply Replied, post #106 · Access › Shortages · 21 Apr 2026 · 0 likes Everything in post #104 holds. The case it does not cover is the one I have. Communication from suppliers: a supplier having supply problems usually communicates them.…
Choosing which test to pay for, given a fixed budget Replied, post #70 · Sourcing › Independent verification · 15 Apr 2026 · 4 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. I would treat that as a working assumption and…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #35 · Compounds › Repair & healing peptides · 10 Apr 2026 · 1 like Everything in post #33 holds. The case it does not cover is the one I have. I think the Stability of BPC-157 question is answerable and has not been answered, which is…
Revisiting: Drawing up with one needle and injecting with another Replied, post #57 · Practice › Administration · 6 Apr 2026 · 2 likes Post #54 answers the question as asked. The question underneath it is different. Alcohol swabbing and letting the site dry is the whole of the preparation for a…
Grapefruit: why this class is not the class that cares Replied, post #84 · Practice › Interactions · 26 Mar 2026 · 28 likes Worth separating grapefruit as a question about the compound from grapefruit as a question about the documentation. They get answered by different people and only one…
Personal import allowances, compared — a second dataset Replied, post #78 · Access › International · 2 Mar 2026 · 2 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #21 · Research Methods › N-of-1 designs · 28 Feb 2026 · 0 likes Post #20 is right about the mechanism and I think understates the practical bit. Withdrawal and reintroduction is the strongest design available to an individual, and…
Trifluoroacetate content and its consequences Replied, post #107 · Analytics › Impurities & related substances · 8 Feb 2026 · 13 likes Where the trifluoroacetate content reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #46 · Practice › Interactions · 4 Feb 2026 · 13 likes Two people in this thread mean different things by Common supplements and are disagreeing about the definition while believing they are disagreeing about the facts.…
[2026 update] What a good consultation looks like from the other side Replied, post #14 · Clinical › Prescriber conversations · 1 Feb 2026 · 0 likes What I want from this good consultation thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #71 · Pharmacology › Pharmacokinetics · 30 Jan 2026 · 0 likes Narrowing post #70, because the general version has more than one answer. The accumulation ratio for weekly dosing with a week-long half-life is around two, which is…
Heterogeneity as information rather than as a nuisance Replied, post #76 · Evidence › Meta-analyses · 25 Jan 2026 · 26 likes Worth separating heterogeneity as a question about the compound from heterogeneity as a question about the documentation. They get answered by different people and only…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #52 · Analytics › Method validation · 3 Jan 2026 · 0 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it.
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #20 · Regional › UK & Ireland · 29 Dec 2025 · 0 likes Post #16 describes the usual case. This is about the unusual one. Private prescribing was covered in the wiki last year and the page has a review date on it, which is a…
Prescription requirements and telehealth models Replied, post #88 · Sourcing › Regulatory · 24 Dec 2025 · 25 likes That is a cleaner way of putting what I was circling around.
Tracking that stops updating and then resumes — the long version Replied, post #50 · Sourcing › Logistics · 12 Dec 2025 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. The strength of my…
Early satiety becoming a problem rather than a benefit Replied, post #13 · Practice › Side effects · 4 Dec 2025 · 1 like Distinguishing three things in the early satiety discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
Robustness: the parameters worth deliberately varying Replied, post #16 · Analytics › Method validation · 23 Nov 2025 · 31 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways. That is my reading. Someone…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #98 · Compounds › Tirzepatide · 18 Nov 2025 · 22 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
What pooling buys you and what it destroys Replied, post #63 · Evidence › Meta-analyses · 10 Nov 2025 · 17 likes Answering the question post #59 raises rather than the one it answers. Adding the boring version of pooling buys, because the interesting version keeps getting posted…
Second pass at: Programming during a large energy deficit Replied, post #29 · Nutrition & Training › Resistance training · 5 Oct 2025 · 5 likes Confirming post #28 from a second method, which matters more than confirming it from a second person. Maintaining load with reduced volume is a reasonable strategy…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #54 · Compounds › Other compounds · 25 Sep 2025 · 12 likes Post #52 is right about the mechanism and I think understates the practical bit. PT-141 was developed from the same family with a different receptor profile, and it has…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #21 · Practice › Interactions · 23 Sep 2025 · 0 likes Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #33 · Practice › Side effects · 2 Sep 2025 · 0 likes Where the nausea timeline discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
When a preprint is the best available evidence and we say so Replied, post #109 · Evidence › Preprints · 28 Aug 2025 · 31 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.…
When a preprint is the best available evidence and we say so Replied, post #68 · Evidence › Preprints · 18 Aug 2025 · 1 like The most useful reply I ever got about preprint was a request to state my units. It sounds like pedantry and it has saved me twice.
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #21 · Evidence › Journal club · 15 Aug 2025 · 28 likes Adding the measurement that post #18 says would settle it. What would change my mind on orforglipron phase 2 is a second dataset collected by someone with no stake in…
A field-by-field walk through a certificate of analysis Replied, post #144 · Analytics › COA interpretation · 18 Jul 2025 · 9 likes Adding the measurement that post #141 says would settle it. A certificate is a statement by its issuer that a defined test was performed on a defined lot and produced a…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #43 · Data & Tools › Calculators · 5 Jul 2025 · 0 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way.
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #59 · Evidence › Journal club · 27 Jun 2025 · 0 likes Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #50 · Compounds › Repair & healing peptides · 25 Jun 2025 · 10 likes Building on post #48 rather than restating it. TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are…
Repeatability versus intermediate precision Replied, post #5 · Analytics › Method validation · 17 Jun 2025 · 5 likes Genuine question rather than a rhetorical one: has anyone here actually observed repeatability versus intermediate precision, as opposed to read about it? The thread is…
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #40 · Compounds › Oral incretins · 31 May 2025 · 10 likes Taking post #37 at face value and following it one step further. Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #98 · Compounds › Tirzepatide · 31 May 2025 · 8 likes Worth separating two things that post #94 runs together. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not…
Travel coolers and how long they really hold — the long version Replied, post #2 · marked as the solution · Devices › Cold chain · 18 May 2025 · 11 likes Arrival condition tells you about the last few hours and very little about the middle of the journey. A pack that is soft on arrival may have been soft for four days or…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #40 · Evidence › Journal club · 16 May 2025 · 8 likes Picking up post #37: that is the part I would want checked first. Where the STEP 4 discussion usually stalls is that nobody wants to say "I do not know" and everyone is…
Follow-up: Documentation that appears only after payment Replied, post #57 · Sourcing › Red flags · 8 May 2025 · 0 likes Post #53 put the caveat in the right place and I want to underline it. The guidelines draw that line for a practical reason as much as a fair one: reports accumulate…
[2026 update] Mood changes: monitoring, and when to involve a professional Replied, post #8 · Wellbeing › Mental health · 4 May 2025 · 0 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #103 · Compounds › Semaglutide · 4 May 2025 · 29 likes Right — I had this wrong and I am glad to have read it before it mattered.
IGF-1 as a surrogate endpoint and its limitations — the long version Started this topic · Compounds › Secretagogues & GH axis · 24 Apr 2025 · 0 likes On the subject in the title: IGF-1 as a surrogate endpoint and its limitations — the long version Working notes rather than a conclusion. A narrow question about IGF-1,…
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #46 · Compounds › Secretagogues & GH axis · 20 Apr 2025 · 7 likes Helpful, and short, which on this subject is harder than long.
Validating a calculator against hand arithmetic — what changed since Replied, post #13 · Data & Tools › Calculators · 12 Apr 2025 · 0 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #123 · Access › International · 25 Mar 2025 · 3 likes The claim about Cross-border purchase within upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says…
Counter-ion form: the field almost nobody reports — one year on Replied, post #111 · Analytics › COA interpretation · 22 Mar 2025 · 20 likes On Counter-ion form, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Maintainer handover: how it works Replied, post #60 · Meta › Wiki maintenance · 17 Mar 2025 · 0 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. I have changed my mind on this once already, so take it as…
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #9 · Clinical › Bloodwork · 16 Mar 2025 · 25 likes If you are new and reading this thread for the answer to hba1c lag: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
Validating a method you did not develop — does this still hold? Replied, post #106 · Analytics › Method validation · 12 Mar 2025 · 15 likes Post #103 and I disagree about the size of the effect, not about the direction. System suitability is the ongoing evidence that a validated method is still performing.…
Follow-up: What other technical communities get right that we do not Replied, post #36 · Lounge › Off topic · 10 Mar 2025 · 12 likes Lower-stakes conversation that does not belong in the technical categories. Still civil, still sourced when a claim is made, but the bar for relevance is lower.
Consistent declarations and why they matter more than clever ones Replied, post #77 · Sourcing › Logistics · 23 Feb 2025 · 0 likes The most useful reply I ever got about consistent declarations was a request to state my units. It sounds like pedantry and it has saved me twice.
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #55 · Compounds › Cagrilintide & amylin analogues · 24 Jan 2025 · 24 likes Narrowing post #52, because the general version has more than one answer. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily…
Why our vendor pages link the storefront and mark it sponsored Replied, post #20 · Sourcing › Vendor reports · 14 Jan 2025 · 1 like Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
Identical chromatograms across two different lots Replied, post #74 · Sourcing › Red flags · 10 Jan 2025 · 17 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for. I would rather say I…
When to suspect the method rather than the sample Replied, post #61 · Analytics › Method validation · 5 Jan 2025 · 24 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
The topic list is dense — is that deliberate? Replied, post #68 · Meta › Site feedback · 17 Dec 2024 · 0 likes Everything in post #64 holds. The case it does not cover is the one I have. Feature request framed as feedback: the category list is long enough that a first-time…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #153 · Analytics › COA interpretation · 16 Dec 2024 · 13 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #54 · Evidence › Journal club · 8 Dec 2024 · 10 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
Why "any advice?" is the least effective ending for a post Replied, post #108 · Start Here › How to Ask · 5 Dec 2024 · 0 likes Everything in post #104 holds. The case it does not cover is the one I have. Avoid "any advice?" at the end. It is so generic that people do not know which part of the…
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #18 · Meta › Wiki maintenance · 26 Oct 2024 · 4 likes That is a cleaner way of putting what I was circling around.
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #106 · Clinical › Bloodwork · 13 Oct 2024 · 2 likes The second most useful thing it does is say clearly when the answer is to book the appointment. That is all I can say without guessing.
Guidelines revision: what changed and why Replied, post #42 · Meta › Announcements · 26 Jul 2024 · 9 likes I think the guidelines revision question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #12 · Compounds › Retatrutide · 16 Jul 2024 · 6 likes Helpful, and easy to find again, which is half of what a good reply is.
Second pass at: Journal club: LEADER as the historical anchor Replied, post #8 · Evidence › Journal club · 7 Jul 2024 · 1 like Post #6 and I disagree about the size of the effect, not about the direction. The figures usually contain the finding and the text usually contains the interpretation.…